CURE - VanEck Genomics and Healthcare Innovators UCITS ETF (USD) (Acc) (IE000B9PQW54)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

FINDEN, SPEICHERN & VERFOLGEN SIE INVESTITIONEN MIT DER CBONDS WATCHLIST

Dank der Cbonds Watchlist bleiben Sie stets über Ihre Investitionen informiert und können fundierte Entscheidungen treffen!

Watchlist

Sie benötigen einen Zugang

Alle auswählen Alle zurücksetzen

Speichern Schließen

(%)

IE000B9PQW54

CURE ISIN

Exchange Traded Funds (ETF)

Fondstyp

VanEck

Anbieter

27,64 USD

NAV pro Aktie | 19/08/2026

06/12/2021

Startdatum

Nein

Ausschüttung von Dividenden

CEOGES

CFI

CURE

Ticker

Formed

Status

Equity

Investitionsobjekt

Healthcare

Sektor

Global

Geographie

MVIS Global Future Healthcare ESG Index

Benchmark

0.35 %

Gesamtkostenquote

Physical

Replikationsmethode

18,2 Mio. USD

Gesamtes Fondsvermögen | 19/08/2026

18,24 Mio. USD

Aktien-Anlageklasse Volumen | 19/08/2026

UCITS

Letzte Daten zum

Zum Vergleichen hinzufügen

Kurse (CURE)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

100 000

Aktien

175 910

ETF & Funds

100 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

Bond-Screener
Watchlist
Excel-Add-In

Zugang erhalten

Kurs-Dynamik

Fund profile

The VanEck Genomics and Healthcare Innovators UCITS ETF seeks to replicate as close as possible the price and yield performance of the MVIS Global Future Healthcare ESG Index by investing in a portfolio comprised primarily of genomics companies developing new ways to treat health problems such as genetic conditions, cancer and conditions related to ageing

CURE profile

The VanEck Genomics and Healthcare Innovators UCITS ETF (USD) (Acc) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Global. The VanEck fund’s base currency is USD and the share class was registered 06.12.2021 with unique ISIN - IE000B9PQW54. Main exchange is London S.E. (USD) and ticker symbol is CURE. The total expense ratio is 0.35%. The VanEck Genomics and Healthcare Innovators UCITS ETF (USD) (Acc) pays dividends 0 time(s) per year.

Struktur CURE auf 19/08/2026

Struktur in Excel herunterladen

Wertpapier	Wertpapier
Moderna Inc	12,5%
Regeneron Pharmaceuticals Inc	8,19%
Vertex Pharmaceuticals Inc	7,43%
Natera Inc	7,15%
Veeva Systems Inc	6,74%
Dexcom Inc	6,17%
Illumina Inc	4,62%
Guardant Health Inc	4,12%
Biontech Se	3,92%
Alnylam Pharmaceuticals Inc	3,36%
Arrowhead Pharmaceuticals Inc	2,61%
Pro Medicus Ltd	2,21%
Insulet Corp	2,14%
Qiagen Nv	2,01%
Ionis Pharmaceuticals Inc	1,65%
Jd Health International Inc	1,55%
Cg Oncology Inc	1,45%
Hims & Hers Health Inc	1,41%
Genscript Biotech Corp	1,35%
Crispr Therapeutics Ag	1,33%
Krystal Biotech Inc	1,29%
10x Genomics Inc	1,19%
Hinge Health Inc	1,18%
Sectra Ab	1,09%
M3 Inc	1,04%
Ptc Therapeutics Inc	0,93%
Twist Bioscience Corp	0,92%
Irhythm Holdings Inc	0,88%
Doximity Inc	0,84%
Adaptive Biotechnologies Corp	0,82%
Caris Life Sciences Inc	0,76%
Grail Inc	0,72%
Ultragenyx Pharmaceutical Inc	0,65%
Veracyte Inc	0,53%
Genedx Holdings Corp	0,53%
Beam Therapeutics Inc	0,42%
Alibaba Health Information Technology L	0,41%
Neogenomics Inc	0,4%
Sarepta Therapeutics Inc	0,39%
Redcare Pharmacy Nv	0,38%
Intellia Therapeutics Inc	0,36%
Omnicell Inc	0,34%
Azenta Inc	0,32%
Tandem Diabetes Care Inc	0,32%
Oxford Nanopore Technologies Plc	0,32%
Teladoc Health Inc	0,3%
Galapagos Nv	0,28%
Ping An Healthcare And Technology Co Lt	0,28%
Phreesia Inc	0,15%
Other/Cash	0,02%

Alle anzeigen Verstecken

Andere - %